Ablation of Bscl2/seipin in hepatocytes does not cause metabolic dysfunction in congenital generalised lipodystrophy
Mutations affecting the BSCL2 gene cause the most severe form of congenital generalised lipodystrophy (CGL). Affected individuals develop severe metabolic complications including diabetes and hepatic steatosis. Bscl2-deficient mice almost entirely reproduce the CGL phenotype. Adipose tissue-specific...
Main Authors: | George D. Mcilroy, Sharon E. Mitchell, Weiping Han, Mirela Delibegović, Justin J. Rochford |
---|---|
Format: | Article |
Language: | English |
Published: |
The Company of Biologists
2020-01-01
|
Series: | Disease Models & Mechanisms |
Subjects: | |
Online Access: | http://dmm.biologists.org/content/13/1/dmm042655 |
Similar Items
-
<i>Bscl2</i> Deficiency Does Not Directly Impair the Innate Immune Response in a Murine Model of Generalized Lipodystrophy
by: Ahlima Roumane, et al.
Published: (2021-01-01) -
A congenital generalized lipodystrophy patient complicated with critical central neurological involvement due to BSCL2 mutations
by: DING Juan,MA Ming-sheng,QIU Zheng-qing
Published: (2021-09-01) -
Characterization of seipin/BSCL2, a protein associated with spastic paraplegia 17
by: Daisuke Ito, et al.
Published: (2008-08-01) -
A Taiwanese Boy With Congenital Generalized Lipodystrophy Caused by Homozygous Ile262fs Mutation in the BSCL2 Gene
by: Hsiu-Hui Huang, et al.
Published: (2010-11-01) -
Gene therapy restores adipose tissue and metabolic health in a pre-clinical mouse model of lipodystrophy
by: Nadine Sommer, et al.
Published: (2022-12-01)